Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
HOPE Council hears literature update on alcohol‑use medications, opioid treatment and emerging GLP‑1 research
Summary
Dr. Calderon, the HOPE Council’s health impact lead, summarized 2024–25 addiction literature and early research linking GLP‑1 drugs to reduced alcohol and substance use.
Dr. Calderon, the HOPE Council’s health impact lead and former behavioral health medical director for Optum, presented a literature review drawn from the American Society of Addiction Medicine’s 2024–25 curation, summarizing recent findings on alcohol use disorder medications, opioid‑use disorder treatment and emerging evidence about GLP‑1 receptor agonists.
Dr. Calderon said hospitalization for a medical problem that coincides with alcohol use disorder is “a great opportunity to engage with people and begin treatment,” and that despite FDA‑approved options — naltrexone, acamprosate and disulfiram — “less than…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
